Article: Effects of prenalterol on cardiac performance and transmural myocardial perfusion in patients with chronic renal failure

The acute haemodynamic effects of the beta-adrenoreceptor agonist, prenalterol, were studied in six patients with chronic end-stage renal failure. Prenalterol 0.8 mg, 1.6 mg, and 3.2 mg was administered i.v. as a bolus, and after the last dose the selective adrenergic beta-1-receptor antagonist metoprolol was administered i.v. in doses of 5 and 10 mg. The haemodynamic effects of the drugs were investigated using impedance cardiography and radionuclide angiocardiography. The main haemodynamic effects were a dose-related chronotropic effect, demonstrated by an increase in heart rate (26%; less than 0.05), and an inotropic effect, shown by an increase in stroke volume index (20%; p less than 0.05) and left ventricular ejection time (12%; p less than 0.05); the cardiac index was increased by 47% (p less than 0.05). Transmural myocardial perfusion (DPTI/SPTI ratio) was decreased by 22% (p less than 0.05) after prenalterol. It is concluded that prenalterol has positive inotropic and chronotropic effects in patients with chronic renal failure, that the improvement in left ventricular performance is at the expense of a decreased transmural myocardial perfusion, and that metoprolol is a specific antidote.

Citing Articles

Dose-response relationship in normal subjects of prenalterol, a beta-adrenergic agonist with positive inotropic and resistance lowering effects.

Rasmussen S, Hoilund-Carlsen P, Hesse B, Hartling O, Fabricius J, Dige-Petersen H Eur J Clin Pharmacol. 1984; 27(5):539-43.

PMID: 6151507 DOI: 10.1007/BF00556889.

References

1.

Svendsen T, Hartling O, TRAP-JENSEN J . Immediate haemodynamic effects of prenalterol, a new adrenergic beta-1-receptor agonist, in healthy volunteers. Eur J Clin Pharmacol. 1980; 18(3):219-23. DOI: 10.1007/BF00563002. View

2.

Drueke T, Fauchet M, Fleury J, Lesourd P, Toure Y, Le Pailleur C . Effect of parathyroidectomy on left-ventricular function in haemodialysis patients. Lancet. 1980; 1(8160):112-4. DOI: 10.1016/s0140-6736(80)90602-9. View

3.

Scott D, Arthur G, BOYES R, Scott D . Cardiovascular effects of prenalterol (H133/22) in normal man. Br J Clin Pharmacol. 1979; 7(4):365-70. PMC: 1429646. DOI: 10.1111/j.1365-2125.1979.tb00947.x. View

4.

Geddes L, Sadler C . The specific resistance of blood at body temperature. Med Biol Eng. 1973; 11(3):336-9. DOI: 10.1007/BF02475543. View

5.

Ariniego R, Waagstein F, Mombay B, Hjalmarson A . Haemodynamic effects of a new beta 1-receptor agonist in acute myocardial infarction. A useful antidote to unwanted cardiac effects of beta-blocking agents. Br Heart J. 1979; 42(2):139-46. PMC: 482127. DOI: 10.1136/hrt.42.2.139. View

6.

Knaus M, Pfister B, Dubach U, Imhof P . Human pharmacology studies with a new, orally active stimulant of cardiac adrenergic beta-receptors. Am Heart J. 1978; 95(5):602-10. DOI: 10.1016/0002-8703(78)90302-2. View

7.

Berger H, Gottschalk A, Zaret B . Radionuclide assessment of left and right ventricular performance. Radiol Clin North Am. 1980; 18(3):441-66. View

8.

Ronn O, Fellenius E, Graffner C, Johnsson G, Lundborg P, Svensson L . Metabolic and haemodynamic effects and pharmacokinetics of a new selective beta 1-adrenoceptor agonist, prenalterol, in man. Eur J Clin Pharmacol. 1980; 17(2):81-6. DOI: 10.1007/BF00562614. View

9.

Hoffman J . Determinants and prediction of transmural myocardial perfusion. Circulation. 1978; 58(3 Pt 1):381-91. DOI: 10.1161/01.cir.58.3.381. View

10.

KUBICEK W, KARNEGIS J, Patterson R, Witsoe D, Mattson R . Development and evaluation of an impedance cardiac output system. Aerosp Med. 1966; 37(12):1208-12. View

11.

Johnsson G, Jordo L, Lundborg P, Ronn O, Wikstrand J . Haemodynamic and tolerance studies in man of a new, orally active, selective beta1-adrenoceptor agonist H 80/62. Eur J Clin Pharmacol. 1978; 13(3):163-70. DOI: 10.1007/BF00609978. View

12.

Reiz S, Friedman A . Hemodynamic and cardiometabolic effects of prenalterol in patients with gram negative septic shock. Acta Anaesthesiol Scand. 1980; 24(1):5-10. DOI: 10.1111/j.1399-6576.1980.tb01495.x. View

Effects of Prenalterol on Cardiac Performance and Transmural Myocardial Perfusion in Patients with Chronic Renal Failure